Aktis Oncology sets sights on first IPO of 2026

By Nnenna Ohaka, Reporter, Partnering and InvestmentShare

BIO-Europe unveils renewed vision as the must-attend global biopharma strategy forum

Savouring the Sweet Smell of Success at BIO-Europe in Cologne

This November, more than 8,000 life sciences leaders, investors, innovators and dealmakers will gather in Cologne, Germany, for BIO-Europe, Europe’s premier partnering event.

Venture Investors Shift Strategy Toward Refined Modalities, Women’s Health and Platform Discipline

Rare disease research

Related news

BIO-Europe unveils renewed vision as the must-attend global biopharma strategy forum

Savouring the Sweet Smell of Success at BIO-Europe in Cologne

Venture Investors Shift Strategy Toward Refined Modalities, Women’s Health and Platform Discipline

Stronger biological proof is reshaping how rare disease therapies are funded and developed